Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

139
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
139

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trajectory of liver-related events following incident cardiovascular disease in MASLD: A 15-year population-based cohort study.

Metabolism: clinical and experimental·2026
Same author

Delphi survey to explore core curriculum for training the next-generation of hepatologists<sup>☆</sup>.

JHEP reports : innovation in hepatology·2026
Same author

Burden and Regional Disparities of MASH-Related Liver Cancer in the Asia-Pacific Region From 1990 to 2023.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Diagnostic innovation and models of care to improve fibrosis detection and risk stratification in steatotic liver disease.

The Lancet regional health. Europe·2026
Same author

MASLD prevalence, incidence and global aspects.

Diabetologia·2026
Same author

The use of pharmacotherapies in non-cirrhotic metabolic dysfunction-associated steatohepatitis: a UK expert consensus.

The lancet. Gastroenterology & hepatology·2026

Related Experiment Video

Updated: Jul 18, 2025

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

12.0K

LEARN algorithm: a novel option for predicting non-alcoholic steatohepatitis.

Gang Li1, Tian-Lei Zheng2, Xiao-Ling Chi3

  • 1MAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

Hepatobiliary Surgery and Nutrition
|August 21, 2023
PubMed
Summary

A new machine learning algorithm, LEARN, uses impedance-based body composition measurements to non-invasively identify non-alcoholic steatohepatitis (NASH). This automated method offers a simpler, more accurate diagnostic approach for fatty liver disease.

Keywords:
Non-alcoholic fatty liver disease (NAFLD)bioeLectrical impEdance Analysis foR Nash (LEARN) algorithmbody compositionnon-alcoholic steatohepatitis (NASH)

More Related Videos

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

955
Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.2K

Related Experiment Videos

Last Updated: Jul 18, 2025

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

12.0K
Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

955
Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.2K

Area of Science:

  • Hepatology
  • Medical Imaging
  • Artificial Intelligence in Medicine

Background:

  • Non-alcoholic steatohepatitis (NASH) diagnosis lacks accurate non-invasive methods.
  • Impedance-based body composition measurements are repeatable and correlate with non-alcoholic fatty liver disease (NAFLD) severity.

Purpose of the Study:

  • To develop a novel, fully automatic machine learning algorithm for NASH identification.
  • To utilize deep neural networks and impedance-based body composition data for NASH diagnosis.

Main Methods:

  • Developed the bioeLectrical impEdance Analysis foR Nash (LEARN) algorithm using a deep neural network.
  • Trained and validated the algorithm on 766 patients with biopsy-proven NAFLD from six Chinese medical centers.
  • Utilized impedance-based body composition, age, sex, hypertension, and diabetes data.

Main Results:

  • The LEARN algorithm accurately predicted NASH likelihood with good discriminatory ability (AUROC 0.81 in training, 0.80 in validation).
  • LEARN outperformed existing non-invasive scores like CK-18 M30, HAIR, ION, and NICE (P < 0.001).
  • The algorithm demonstrated robust performance across patient subgroups and with partial data.

Conclusions:

  • The LEARN algorithm provides a simple, automated, and non-invasive method for NASH identification.
  • This approach addresses the unmet need for accurate non-invasive NASH diagnostics.